SCHEMBL6637018

SCHEMBL6637018

CN(Cc1ccccc1)c1ccc2c(c1)nc(CNc1ccc(C#N)cc1)n2C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 11/20 0.48
▸ RAB9A P51151 11/20 0.48
▸ SMN1; SMN2 Q16637 5/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ HDAC6 Q9UBN7 4/20 0.46
▸ TP53 P04637 4/20 0.46
▸ L3MBTL1 Q9Y468 3/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ NFKB1 P19838 2/20 0.46
▸ NFKB2 Q00653 2/20 0.46
▸ RELA Q04206 2/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ KMT2A Q03164 3/20 0.45
▸ MAPT P10636 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ GFER P55789 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ PKM P14618 2/20 0.44
▸ HTT P42858 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6637343 0.84 HDAC6 (0.49) NPC1RAB9ASMN1; SMN2KDM4EHDAC6
SCHEMBL6633497 0.83 KLK1 (0.65) HDAC6F2KLK1KLK5
SCHEMBL6634815 0.80 NPC1 (0.52) NPC1RAB9ASMN1; SMN2KDM4EHDAC6
SCHEMBL7447463 0.79 NPC1 (0.72) NPC1RAB9ASMN1; SMN2KDM4ETP53
SCHEMBL6775295 0.77 HDAC6 (0.64) NPC1RAB9AHDAC6LMNAF2
SCHEMBL14914339 0.77 HDAC6 (0.51) NPC1RAB9ASMN1; SMN2KDM4EHDAC6
SCHEMBL30937423 0.76 HDAC6 (0.62) NPC1RAB9ASMN1; SMN2KDM4EHDAC6
SCHEMBL7380330 0.75 NPC1 (0.46) NPC1RAB9ASMN1; SMN2KDM4EHDAC6
SCHEMBL6636532 0.74 F2 (0.53) NPC1RAB9AHDAC6F2
SCHEMBL19339630 0.74 HDAC6 (0.48) NPC1RAB9ASMN1; SMN2KDM4EHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 — — EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 — — US disclosed
Send feedback